Comparison of PrP transcription and translation in two murine myeloma cell lines

Journal of Neuroimmunology

Volumn 140, Issue 1-2, 2003, Pages 137-142

  Kim, Jae Il ^a   Kuizon, Salomon ^a   Rubenstein, Richard ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Monoclonal antibodies; Myeloma cell lines; Prion protein

Indexed keywords

PRION PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; MOUSE; MYELOMA CELL; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; RNA TRANSLATION;

EID: 0037967515     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00181-4     Document Type: Article

References (35)

1. Bodemer W. The use of monoclonal antibodies in human prion disease. Naturwissenschaften. 86:1999;212-220.
2. Bonifacino J.S., Dell'Angelica E.C., Springer T.A. Immunoprecipitation. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology. vol. 2:1999;10.16.1-10.16.29 Wiley, New York.
3. Brown D.R. Copper and prion disease. Brain Res. Bull. 55:2001;165-173.
4. Büeler H., Fischer M., Lang Y., Bluthmann H., Lipp H.-L., DeArmond S.J., Prusiner S.B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 356:1992;577-582.
5. Sc and infectivity - do the pieces fit? Trends Neurosci. 17:1994;148-149.
6. Cashman N.R., Loertscher R., Nalbantoglu J., Shaw I., Kascsak R.J., Bolton D.C., Bendheim P.E. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell. 61:1990;185-192.
7. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., Jefferys J.G. Prion protein is necessary for normal synaptic function. Nature. 370:1994;295-297.
8. Demart S., Fournier J.G., Creminon C., Frobert Y., Lamoury F., Marce D., Lasmezas C., Dormont D., Grassi J., Deslys J.P. New insight into abnormal prion protein using monoclonal antibodies. Biochem. Biophys. Res. Commun. 265:1999;652-657.
9. Enari M., Flechsig E., Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. U. S. A. 98:2001;9295-9299.
10. Harlow E., David L. Monoclonal antibodies. Harlow E., David L. Antibodies: A Laboratory Manual. 1988;139-243 Cold Spring Harbor Laboratory, New York.
11. Harmeyer S., Pfaff E., Groschup M.H. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. J. Gen. Virol. 79:1998;937-945.
12. Heppner F.L., Musahl C., Arrighi I., Klein M.A., Rulicke T., Oesch B., Zinkernagel R.M., Kalinke U., Aguzzi A. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science. 294:2001;178-182.
13. Kascsak R.J., Rubenstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61:1987;3688-3693.
14. Kascsak R.J., Tonna-DeMasi M., Fersko R., Rubenstein R., Carp R.I., Powers J.M. The role of antibodies to PrP in the diagnosis of transmissible spongiform encephalopathies. Dev. Biol. Stand. 80:1993;141-151.
15. Kascsak R.J., Fersko R., Pulgiano D., Rubenstein R., Carp R.I. Immunodiagnosis of prion disease. Immunol. Invest. 26:1997;259-268.
16. Sc)-specific epitope defined by a monoclonal antibody. Nature. 390:1997;74-77.
17. 0/0 mice. Mol. Med. 2:1996;725-734.
18. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Matsumoto Y., Yokoyama T., Itohara S., Onodera T. Prions prevent neuronal cell-line death. Nature. 400:1999;225-226.
19. Li R., Liu T., Wong B.S., Pan T., Morillas M., Swietnicki W., O'Rourke K., Gambetti P., Surewicz W.K., Sy M.S. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J. Mol. Biol. 301:2000;567-573.
20. Li R., Liu D., Zanusso G., Liu T., Fayen J.D., Huang J.H., Petersen R.B., Gambetti P., Sy M.S. The expression and potential function of cellular prion protein in human lymphocytes. Cell Immunol. 207:2001;49-58.
21. Lowry O.H., Roseborough N.J., Farr L.A., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
22. O'Rourke K.I., Baszler T.V., Miller J.M., Spraker T.R., Sadler-Riggleman I., Knowles D.P. Monoclonal antibody F89/160.1.5 defines a conserved epitope on the ruminant prion protein. J. Clin. Microbiol. 36:1998;1750-1755.
23. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., Prusiner S.B. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10962-10966.
24. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Dwek R.A., Burton D.R., Prusiner S.B. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 412:2001;739-743.
25. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13363-13383.
26. Prusiner S.B., Groth D., Serban A., Koehler R., Foster D., Torchia M., Burton D., Yang S.-L., DeArmond S.J. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10608-10612.
27. Rubenstein R., Kascsak R.J., Papini M., Kascsak R., Carp R.I., LaFauci G., Meloen R., Langeveld J. Immune surveillance and antigen conformation determines humoral immune response to the prion protein immunogen. J. Neurovirol. 5:1999;401-413.
28. C directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 276:2001;44604-44612.
29. Tobler I., Gaus S.E., Deboer T., Achermann P., Fischer M., Rulicke T., Moser M., Oesch B., McBride P.A., Manson J.C. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature. 380:1996;639-642.
30. Wechselberger C., Wurm S., Pfarr W., Höglinger O. The physiological functions of prion protein. Exp. Cell Res. 281:2002;1-8.
31. Westaway D., Goodman P.A., Mirenda C.A., McKinley M.P., Carlson G.A., Prusiner S.B. Distinct prion proteins in short and long scrapie incubation period mice. Cell. 51:1987;651-662.
32. Williamson R.A., Peretz D., Smorodinsky N., Bastidas R., Serban H., Mehlhorn I., DeArmond S.J., Prusiner S.B., Burton D.R. Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein. Proc. Natl. Acad. Sci. U. S. A. 93:1996;7279-7282.
33. Wong B.S., Green A.J., Li R., Xie Z., Pan T., Liu T., Chen S.G., Gambetti P., Sy M.S. Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J. Pathol. 194:2001;9-14.
34. Yokoyama T., Kimura K.M., Ushiki Y., Yamada S., Morooka A., Nakashiba T., Sassa T., Itohara S. In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J. Biol. Chem. 276:2001;11265-11271.
35. Zanusso G., Liu D., Ferrari S., Hegyi I., Yin X., Aguzzi A., Hornemann S., Liemann S., Glockshuber R., Manson J.C., Brown P., Petersen R.B., Gambetti P., Sy M.S. Prion protein expression in different species: analysis with a panel of new mAbs. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8812-8816.